An observational study in Non-cardiac Disease, sponsored by University of Leipzig. Completed at 1 site in Germany. Open to participants aged 50 Years and older. Per ClinicalTrials.gov, last updated 2024-04-03.
Sponsored by University of Leipzig · Observational
We aim to examine, whether hospitalization is associated with higher high-sensitivity cardiac troponin T (hs-cTnT) serum concentrations in patients without a cardiac disease.
High-sensitivity cardiac troponin T (hs-cTnT) values will be obtained in hospitalized patients a) without a diagnosed or suspected cardiac disease, and b) with an acute medical condition that is not commonly associated with an increase of hs-cTnT concentrations. As a reference, a second sampling of blood for an analysis of the hs-cTnT serum concentration will be obtained in the same patients after discharge (60 days after hospitalization).
1,916 studies on the registry are indexed under Hypersensitivity; 265 are open to participants now.
This study's enrollment of 177 is above the median of 115 across 479 observational studies indexed under Hypersensitivity.
Browse Hypersensitivity studies →University of Leipzig is the lead sponsor of 147 studies on the registry; 24 are open to participants now.
Counted across the registry records on this site, refreshed daily.
312 patients with an acute, non-cardiac medical condition of low, medium or high severity (104 patients per group)
Exclusion Criteria:
Hospitalized patients without a diagnosed or suspected cardiac disease and with an acute medical condition of low severity (e.g. patients with retinal detachment)
Diagnostic Test: Analysis of hs-cTnT serum concentration at hospitalization · Diagnostic Test: Analysis of hs-cTnT serum concentration after discharge
Hospitalized patients without a diagnosed or suspected cardiac disease and with an acute medical condition of medium severity (e.g. patients with an uncomplicated acute pancreatitis oder an acute exacerbation of a chronic inflammatory bowel disease)
Diagnostic Test: Analysis of hs-cTnT serum concentration at hospitalization · Diagnostic Test: Analysis of hs-cTnT serum concentration after discharge
Hospitalized patients without a diagnosed or suspected cardiac disease and with an acute medical condition of high severity (e.g. patients with a proximal femoral fracture)
Diagnostic Test: Analysis of hs-cTnT serum concentration at hospitalization · Diagnostic Test: Analysis of hs-cTnT serum concentration after discharge
Analysis of the hs-cTnT serum concentration in the blood drawn at the day of hospitalization
Analysis of the hs-cTnT serum concentration in the blood drawn after discharge (60 days after hospitalization)
Difference of the hs-cTnT concentration at hospitalization and after discharge
Time frame: 60 days
Difference of the hs-cTnT concentration at hospitalization and after discharge in acute medical conditions of low severity
Time frame: 60 days
Difference of the hs-cTnT concentration at hospitalization and after discharge in acute medical conditions of medium severity
Time frame: 60 days
Difference of the hs-cTnT concentration at hospitalization and after discharge in acute medical conditions of high severity
Time frame: 60 days
Prediction of 1-year-mortality by hs-cTnT concentration
Time frame: 1 year
Prediction of 1-year-hospitalization rate due to a cardiovascular disease by hs-cTnT concentration
Time frame: 1 year
Plan to share: Undecided — Available upon reasonable scientific request
No publications or documents are linked to this record.
This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Leipzig